Provides commercial real estate financing for investment projects, development finance, and cross-border portfolios. Now — the numbers.
The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.
Average growth of 9% a year over the last 4 years. Red columns mark years that ended in a loss.
At this burn rate the cash pile isn’t the pressing question — for now, time is on the company’s side.
This company is not turning a profit, so the market is pricing its sales instead: 0.2× for every dollar of annual revenue.
No analyst target is on record for this company.
The stock trades 59% below its peak. The market has trimmed its expectations for the company.
Over the last 4 years, sales grew about 9% a year on average.
The company sells $2.6B a year; the problem isn’t sales — it’s costs running above that number.
A loss of $329.5M against $2.6B in annual sales.
Since the drop from its peak, buyer appetite hasn’t come back.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
One-line summary: few numbers, an untested story. Keep watching.
Not covered, because the filings we hold do not carry it: earnings execution, the revenue breakdown.